Welcome to the website of the Center for Vaccine Research,
an organization leading Korea’s vaccine research and development.

The COVID-19 pandemic declared in 2020 posed a significant threat to people’s lives globally,

causing social and economic damage. As mRNA vaccines combined with new technology began to take shape,

once again we have come to realize the importance of rapid vaccine development and production capabilities.

As a national vaccine R&D control tower, the Center for Vaccine Research established under the National Institute

of Infectious Diseases (NIID) in September 2020 has been drawing up national vaccine development strategy,

securing next generation core technology through basic research, and operating the National Culture Collection for Pathogens (NCCP).

Moreover, the Center has been providing preclinical and clinical trial support networks and pathogen resources as well as

Biosafety Level 3 (BL3), Animal Biosafety Level 2 and 3 (ABL2, 3), and Good Clinical Laboratory Practice (GCLP) facilities.

These are a full-cycle support system in place, in an effort to make vaccines more practical and aid the private sector.

With the aforementioned support system and cooperation between private, public, academic, and research institutions

we engage in, we are taking the lead in the national vaccine development.

The Center for Vaccine Research will stay committed as a leading organization,

thereby ensuring that Korea emerges as a vaccine powerhouse going forward.

Thank you.

Dokeun Kim, Director General
Center for Vaccine Research